Dr. Caroline Shiboski Appointed Interim Chair of Orofacial Sciences
Caroline Shiboski, DDS, MPH, PhD, a longtime professor in the UCSF School of Dentistry's Department of Orofacial Sciences (OFS), has been appointed Interim Chair of OFS and will assume her duties in that role effective July 1, 2014.
Dr. Shiboski will take over as interim chair of the department following the retirement of the current chair, Dr. Deborah Greenspan.
Says Dean John D.B. Featherstone: "I am very pleased that Dr. Caroline Shiboski has agreed to accept the position of interim chair of Orofacial Sciences. I look forward to working with her while the search for the permanent chair takes place. She is very well supported by faculty and staff."
In addition to being a Professor in the Department of Orofacial Sciences, Dr. Shiboski is also the director of the Oral Medicine Clinical Center as well as the Post-Graduate Residency program in Oral Medicine at the UCSF School of Dentistry.
She obtained her DDS from the Université René Descartes in Paris, and has advanced training in Epidemiology (with an MPH and a PhD from UC Berkeley) and Oral Medicine (she is a certified Diplomate of the American Board of Oral Medicine). Her research experience focuses on the epidemiology of oral cancer and of oral manifestations related to immune dysfunction in various populations.
Dr. Shiboski has received multiple NIH grants and contracts since 1994. She implemented a collaborative study, funded through the AIDS Fogarty Program, exploring oral candidiasis as a surrogate marker of HIV disease progression among women in Zimbabwe. While visiting Zimbabwe once a year from 1999 to 2005 as part of this project, she also developed and taught the Oral Medicine curriculum of the Department of Dentistry at the University of Zimbabwe School of Medicine.
She is the principal investigator of the Sjögren’s International Collaborative Clinical Alliance Biorepository, an NIH contract based on a previous contract that established new classification criteria for Sjögren’s Syndrome (approved by the American College of Rheumatology), and that developed a data and biospecimen repository for this disease. The aim of the new contract is to disseminate SICCA data and biospecimens to scientists around the world to advance the field with pathogenesis, epidemiologic, and genetic studies.
Dean Featherstone asks that the school community join him in congratulating Dr. Shiboski and welcoming her to her new role.
Dr. Caroline Shiboski